Suppr超能文献

雄激素受体表达预测乳腺癌生存:遗传和表观遗传事件的作用。

Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.

机构信息

School of Chemistry and Molecular Biosciences, The University of Queensland, St, Lucia 4072 Queensland, Australia.

出版信息

BMC Cancer. 2012 Apr 2;12:132. doi: 10.1186/1471-2407-12-132.

Abstract

BACKGROUND

Breast cancer outcome, including response to therapy, risk of metastasis and survival, is difficult to predict using currently available methods, highlighting the urgent need for more informative biomarkers. Androgen receptor (AR) has been implicated in breast carcinogenesis however its potential to be an informative biomarker has yet to be fully explored. In this study, AR protein levels were determined in a cohort of 73 Grade III invasive breast ductal adenocarcinomas.

METHODS

The levels of Androgen receptor protein in a cohort of breast tumour samples was determined by immunohistochemistry and the results were compared with clinical characteristics, including survival. The role of defects in the regulation of Androgen receptor gene expression were examined by mutation and methylation screening of the 5' end of the gene, reporter assays of the 5' and 3' end of the AR gene, and searching for miRNAs that may regulate AR gene expression.

RESULTS

AR was expressed in 56% of tumours and expression was significantly inversely associated with 10-year survival (P = 0.004). An investigation into the mechanisms responsible for the loss of AR expression revealed that hypermethylation of the AR promoter is associated with loss of AR expression in breast cancer cells but not in primary breast tumours. In AR negative breast tumours, mutation screening identified the same mutation (T105A) in the 5'UTR of two AR negative breast cancer patients but not reported in the normal human population. Reporter assay analysis of this mutation however found no evidence for a negative impact on AR 5'UTR activity. The role of miR-124 in regulating AR expression was also investigated, however no evidence for this was found.

CONCLUSION

This study highlights the potential for AR expression to be an informative biomarker for breast cancer survival and sets the scene for a more comprehensive investigation of the molecular basis of this phenomenon.

摘要

背景

乳腺癌的预后,包括对治疗的反应、转移风险和生存,使用目前可用的方法难以预测,这突出表明急需更具信息量的生物标志物。雄激素受体(AR)已被牵涉到乳腺癌的发生发展中,但其作为一种信息生物标志物的潜力尚未得到充分探索。在本研究中,通过免疫组织化学测定了 73 例 III 级浸润性乳腺导管腺癌队列中的 AR 蛋白水平。

方法

通过免疫组织化学测定了乳腺癌肿瘤样本队列中雄激素受体蛋白的水平,并将结果与临床特征(包括生存)进行了比较。通过对基因 5'端的突变和甲基化筛选、AR 基因 5'和 3'端的报告基因检测以及寻找可能调节 AR 基因表达的 miRNA,研究了雄激素受体基因表达调控缺陷的作用。

结果

AR 在 56%的肿瘤中表达,表达与 10 年生存率呈显著负相关(P = 0.004)。对导致 AR 表达缺失的机制进行研究发现,AR 启动子的高甲基化与乳腺癌细胞中 AR 表达缺失相关,但与原发性乳腺癌无关。在 AR 阴性乳腺癌中,突变筛选在两名 AR 阴性乳腺癌患者的 5'UTR 中发现了相同的突变(T105A),但在正常人群中未报道。然而,对该突变的报告基因分析未发现其对 AR 5'UTR 活性有负面影响的证据。还研究了 miR-124 在调节 AR 表达中的作用,但未发现证据。

结论

本研究强调了 AR 表达作为乳腺癌生存的信息生物标志物的潜力,并为更全面地研究这一现象的分子基础奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec2/3349557/171904f0eddb/1471-2407-12-132-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验